Weeks after AstraZeneca and Daiichi Sankyo were able to move the bar in the treatment of metastatic breast cancer with Enhertu, Gilead Sciences is answering that challenge with Trodelvy.
https://www.pharmalive.com/wp-content/uploads/2022/04/Gilead-Secures-Legal-Victory-in-Battle-Against-HIV-Drug-Fraud-BioSpace-4-20-22.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-16 11:24:222022-08-17 09:36:32Gilead’s Trodelvy gives Enhertu a run for its money in metastatic breast cancer
